A Phase 1b Study of LY2835219 in Combination with Multiple Single-Agent Options for Patients with Stage IV NSCLC - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1b Study of LY2835219 in Combination with Multiple Single-Agent Options for Patients with Stage IV NSCLC

Type of Cancer
Lung
Locations
Hackensack
Sponsor
Eli Lilly
Protocol Number
I3Y-MC-JPBJ
Cancer Diagnosis
To Learn More Call
201-510-0910